Biopharma News : Biopharma and Pharma news from all around the world :
- QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
- Copley Equity Partners Completes Acquisition of Vital Delivery Solutions
- Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF
- Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date
- Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
- KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
- Kallyope To Present at the 44th Annual J.P. Morgan Healthcare Conference
- Future Forward Labs Appoints Dr. Delia DeBuc as Applied Science Mentor to Advance Applied Physics and Biomedical Innovation
- New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis
- Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
- Immunome Announces Pricing of Public Offering of Common Stock
- Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
- Atom Therapeutics Launches Multi-Regional Phase 2 Trial of ABP-745 for Atherosclerotic Cardiovascular Disease (ASCVD)
- Tubulis to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Latent Labs Announces Latent-X2: AI-Generated Antibodies With Drug-Like Developability and Low Ex Vivo Immunogenicity
- TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth
- LEO Pharma Appoints Marika Murto to Lead Global Product Strategy
- RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)
- Calluna Pharma Announces the Appointment of Gijs van den Brink, MD, PhD, as Independent Director
- Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
- Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
- Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
- Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
- Washington Launches New Tools to Help Medical Professionals Deliver Life-saving Medications for Opioid Use Disorder
- Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger
- GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience
- Hercules Pharmaceuticals Appoints Ali Ahmed as Chief Commercial Officer
- Strategies to Succeed in the $5+ Billion Tourette Syndrome Drugs Market, 2026-2034 – ResearchAndMarkets.com
- The OpenFold Consortium Names Dr. Jan Domanski as Senior Science Lead to Drive the Next Generation of Open Source AI Models for Structural Biology and Drug Discovery
- Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models
News about Biotech, Pharma, Biopharma, Medical Devices, Diagnostics, Digital Health
- Cantourage Group SE expects EBITDA for 2025 to exceed current market expectations based on preliminary figures
- Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
- Abivax to be Added to Nasdaq Biotechnology Index
- DOUGLAS Group achieves solid sales growth and doubles net income in volatile financial year 2024/25
- Correction of a release from 17/12/2025, 16:06 CET/CEST – Updated Conference Call Invitation Links
- Conference Call Invitation
- Secarna Pharmaceuticals and Protalix Biotherapeutics Enter into Collaboration and Option Agreement
- Heidelberg Pharma: Letter from the CEO
- Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth
- MRM Health Enters Strategic Collaboration with Oncode Institute and the Netherlands Cancer Institute to Accelerate Program on Microbiome-Based Therapies that Enhance Cancer Immunotherapy
- Galenica further expands online offering and acquires majority stake in Puravita
- Strategic Investment: CANSOUL acquires stake in SYNBIOTIC
- Vitruvia Medical AG: successfull capital increase and strengthening of the financial structure
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
- Biotech Showcase™ 2026 Returns to San Francisco During JPM Week as a Premier Destination for Dealmakers
- Award-Winning Liver PET Tracer Highlights the Strength of Our Innovation Portfolio
- Award-Winning Liver PET Tracer Highlights the Strength of Our Innovation Portfolio
- PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet Growing Demand for Peptide Supply in Metabolic Therapies
- Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease
- Expansion of the Management Board of M1 Kliniken AG
- SCHOTT Pharma delivers on full-year revenue and profitability targets
- BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
- Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
- Cantourage appoints new member to its Management Board: Monique Jaqqam becomes Chief Financial Officer – Supervisory Board prolongs CEO Philip Schetter’s mandate by five years
- Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS)
- Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz
- Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership
- Xlife Sciences AG Announces Exit of 12 Project Companies to Grupo Landsteiner and the Creation of a Scalable Transcontinental Life Sciences Platform
- Reorganization of the Eckert & Ziegler Executive Board
- SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance
- What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives
- The 3D-Flow Architecture Breakthrough: A Universal, Scalable Digital Processor for Real-Time Pattern Recognition in High-Rate Data Streams — A Platform to Save Millions of Lives and Billions of Euros
- Clemson University and Nordic Wellness Launch Groundbreaking Partnership to Transform the Student Mental Health Crisis
- Is MEDVi the Best GLP-1 Supplier for 2026? Platform Lists Compounded Semaglutide at $179/Month With No Contract Ahead of Weight Loss Season
- Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze
- AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
- Lifeward Appoints Bob Marshall as Chairman of the Board
- NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
- Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
- Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
- Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
- Tevogen CEO Donates Personal Shares to Support Local Fire Department
- Tevogen CEO Donates Personal Shares to Support Local Fire Department
- Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
- Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
- OncoInv and MaxBloch Partner to Expand Early Cancer Detection Across Central America
- OncoInv and MaxBloch Partner to Expand Early Cancer Detection Across Central America
- Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
- Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
- Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
- Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027
- Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027
- Cue Biopharma Announces Pricing of $10 Million Public Offering
- Cue Biopharma Announces Pricing of $10 Million Public Offering
- IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
- IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
- NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives
- NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives
- Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
- Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites for more info.
Biopharma News – Pharma News